ApoE-modified liposomes mediate the antitumour effect of survivin promoter-driven HSVtk in hepatocellular carcinoma
Cancer Gene Therapy, Published online: 23 October 2019; doi:10.1038/s41417-019-0145-3ApoE-modified liposomes mediate the antitumour effect of survivin promoter-driven HSVtk in hepatocellular carcinoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 23, 2019 Category: Cancer & Oncology Authors: Xiuli Mu Xi Wang Yan Wei Chaochao Wen Qi Zhang Chunyang Xu Chang Liu Chan Zhang Fanxiu Meng Na Zhao Tao Gong Rui Guo Gongqin Sun Gaopeng Li Hongwei Zhang Qin Qin Jun Xu Xiushan Dong Lumei Wang Baofeng Yu Source Type: research

Identification of genes of four malignant tumors and a novel prediction model development based on PPI data and support vector machines
Cancer Gene Therapy, Published online: 23 October 2019; doi:10.1038/s41417-019-0143-5Identification of genes of four malignant tumors and a novel prediction model development based on PPI data and support vector machines (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 23, 2019 Category: Cancer & Oncology Authors: Ming Li Ping Wang Ning Zhang Lu Guo Yuan-Ming Feng Source Type: research

Application of RNA-sequencing to identify transcriptome modification by DCLK1 in colorectal cancer cells
Cancer Gene Therapy, Published online: 21 October 2019; doi:10.1038/s41417-019-0144-4Application of RNA-sequencing to identify transcriptome modification by DCLK1 in colorectal cancer cells (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 21, 2019 Category: Cancer & Oncology Authors: Lianna Li Hao Mei Abednego Nii Adom Commey Source Type: research

GATA3 suppresses human fibroblasts-induced metastasis of clear cell renal cell carcinoma via an anti-IL6/STAT3 mechanism
Cancer Gene Therapy, Published online: 21 October 2019; doi:10.1038/s41417-019-0146-2GATA3 suppresses human fibroblasts-induced metastasis of clear cell renal cell carcinoma via an anti-IL6/STAT3 mechanism (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 21, 2019 Category: Cancer & Oncology Authors: Qianqian Shi Renfang Xu Guanglai Song Hao Lu Dong Xue Xiaozhou He Ying Xia Source Type: research

Specific glioblastoma multiforme prognostic-subtype distinctions based on DNA methylation patterns
Cancer Gene Therapy, Published online: 16 October 2019; doi:10.1038/s41417-019-0142-6Specific glioblastoma multiforme prognostic-subtype distinctions based on DNA methylation patterns (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 16, 2019 Category: Cancer & Oncology Authors: Huihui Ma Chenggang Zhao Zhiyang Zhao Lizhu Hu Fang Ye Hongzhi Wang Zhiyou Fang Yuejin Wu Xueran Chen Source Type: research

A qualitative transcriptional signature for determining the grade of colorectal adenocarcinoma
Cancer Gene Therapy, Published online: 09 October 2019; doi:10.1038/s41417-019-0139-1A qualitative transcriptional signature for determining the grade of colorectal adenocarcinoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 9, 2019 Category: Cancer & Oncology Authors: Hailong Zheng Kai Song Yelin Fu Tianyi You Jing Yang Wenbing Guo Kai Wang Liangliang Jin Yunyan Gu Lishuang Qi Wenyuan Zhao Zheng Guo Source Type: research

CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma
Cancer Gene Therapy, Published online: 08 October 2019; doi:10.1038/s41417-019-0140-8CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 8, 2019 Category: Cancer & Oncology Authors: Luqing Tong Jiabo Li John Choi Ayush Pant Yuanxuan Xia Christopher Jackson Peidong Liu Li Yi Elias Boussouf Michael Lim Xuejun Yang Source Type: research

Integrative analysis reveals CRHBP inhibits renal cell carcinoma progression by regulating inflammation and apoptosis
Cancer Gene Therapy, Published online: 01 October 2019; doi:10.1038/s41417-019-0138-2Integrative analysis reveals CRHBP inhibits renal cell carcinoma progression by regulating inflammation and apoptosis (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 1, 2019 Category: Cancer & Oncology Authors: Kang Yang Yusha Xiao Tao Xu Weimin Yu Yuan Ruan Pengcheng Luo Fan Cheng Source Type: research

Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer
Cancer Gene Therapy, Published online: 24 September 2019; doi:10.1038/s41417-019-0137-3Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - September 24, 2019 Category: Cancer & Oncology Authors: Ana Rosa Rama Rosa Hern ández Gloria Perazzoli Laura Cabeza Consolaci ón Melguizo Celia V élez Jose Prados Source Type: research

SOX17, β-catenin and CyclinD1 expression in the endometrioid adenocarcinoma and influence of 5-AZA on expression
Cancer Gene Therapy, Published online: 23 September 2019; doi:10.1038/s41417-019-0135-5SOX17, β-catenin and CyclinD1 expression in the endometrioid adenocarcinoma and influence of 5-AZA on expression (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - September 23, 2019 Category: Cancer & Oncology Authors: Yu-Mei Liao Yang Song Yuan-Kun Li Jie-Hua Du Ying Zhou Source Type: research

Circular RNAs: epigenetic regulators in cancerous and noncancerous skin diseases
Cancer Gene Therapy, Published online: 03 September 2019; doi:10.1038/s41417-019-0130-xCircular RNAs: epigenetic regulators in cancerous and noncancerous skin diseases (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - September 3, 2019 Category: Cancer & Oncology Authors: Abbas Abi Najmeh Farahani Ghader Molavi Seyed Mohammad Gheibi Hayat Source Type: research

Emerging role of exosomes as promising diagnostic tool for cancer
Cancer Gene Therapy, Published online: 03 September 2019; doi:10.1038/s41417-019-0136-4Emerging role of exosomes as promising diagnostic tool for cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - September 3, 2019 Category: Cancer & Oncology Authors: Vijayashree Priyadharsini Jayaseelan Source Type: research

Oncolytic activity of HF10 in head and neck squamous cell carcinomas
Cancer Gene Therapy, Published online: 03 September 2019; doi:10.1038/s41417-019-0129-3Oncolytic activity of HF10 in head and neck squamous cell carcinomas (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - September 3, 2019 Category: Cancer & Oncology Authors: Shinichi Esaki Fumi Goshima Haruka Ozaki Gaku Takano Yoshimi Hatano Daisuke Kawakita Kei Ijichi Takahiro Watanabe Yoshitaka Sato Takayuki Murata Hiromitsu Iwata Yuta Shibamoto Shingo Murakami Yukihiro Nishiyama Hiroshi Kimura Source Type: research

Companion gene mutations and their clinical significance in AML with double mutant CEBPA
Cancer Gene Therapy, Published online: 03 September 2019; doi:10.1038/s41417-019-0133-7Companion gene mutations and their clinical significance in AML with double mutant CEBPA (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - September 3, 2019 Category: Cancer & Oncology Authors: Yang Zhang Fang Wang Xue Chen Yu Zhang Mingyu Wang Hong Liu Wen Teng Panxiang Cao Daijing Nie Xiaoli Ma Tong Wang Peihua Lu Hongxing Liu Source Type: research

Alkaliptosis: a new weapon for cancer therapy
Cancer Gene Therapy, Published online: 30 August 2019; doi:10.1038/s41417-019-0134-6Alkaliptosis: a new weapon for cancer therapy (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - August 30, 2019 Category: Cancer & Oncology Authors: Jiao Liu Feimei Kuang Rui Kang Daolin Tang Source Type: research

SGPL1321 mutation: one main trigger for invasiveness of pediatric alveolar rhabdomyosarcoma
Cancer Gene Therapy, Published online: 27 August 2019; doi:10.1038/s41417-019-0132-8SGPL1321 mutation: one main trigger for invasiveness of pediatric alveolar rhabdomyosarcoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - August 27, 2019 Category: Cancer & Oncology Authors: Anna Adamus Nadja Engel Guido Seitz Source Type: research

Synergistic antitumor effect on cervical cancer by rational combination of PD1 blockade and CRISPR-Cas9-mediated HPV knockout
Cancer Gene Therapy, Published online: 27 August 2019; doi:10.1038/s41417-019-0131-9Synergistic antitumor effect on cervical cancer by rational combination of PD1 blockade and CRISPR-Cas9-mediated HPV knockout (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - August 27, 2019 Category: Cancer & Oncology Authors: Shuai Zhen Jiaojiao Lu Yun-Hui Liu Wei Chen Xu Li Source Type: research

Calcium-sensing receptor antagonist NPS-2143 suppresses proliferation and invasion of gastric cancer cells
Cancer Gene Therapy, Published online: 08 August 2019; doi:10.1038/s41417-019-0128-4Calcium-sensing receptor antagonist NPS-2143 suppresses proliferation and invasion of gastric cancer cells (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - August 8, 2019 Category: Cancer & Oncology Authors: Zong-Lin Zhang Zheng-Rong Li Jun-Sheng Li Su-Rong Wang Source Type: research

Cancer immunotherapy using the Fusion gene of Sendai virus
Cancer Gene Therapy, Published online: 06 August 2019; doi:10.1038/s41417-019-0126-6Cancer immunotherapy using the Fusion gene of Sendai virus (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - August 6, 2019 Category: Cancer & Oncology Authors: Jiayu A. Tai Chin Yang Chang Tomoyuki Nishikawa Yasufumi Kaneda Source Type: research

Abnormal expression of menin predicts the pathogenesis and poor prognosis of adult gliomas
Cancer Gene Therapy, Published online: 06 August 2019; doi:10.1038/s41417-019-0127-5Abnormal expression of menin predicts the pathogenesis and poor prognosis of adult gliomas (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - August 6, 2019 Category: Cancer & Oncology Authors: Zhan-Feng Wang Xin-Yu Hong Ling-Yu Zhu Li Zhang Huan Qiu Yuan-Yuan Zhang Ming-Cheng Yuan Xing-Li Zhao Qi-Fan Zheng Guang-Hui Jin Source Type: research

The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients
Cancer Gene Therapy, Published online: 18 July 2019; doi:10.1038/s41417-019-0123-9The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 18, 2019 Category: Cancer & Oncology Authors: Rady E. El-Araby Mahmoud A. Khalifa Mona M. Zoheiry Manal Y. Zahran Mohamed I. Rady Raafat A. Ibrahim Mohamed D. El-Talkawy Faiza M. Essawy Source Type: research

Viral vector: potential therapeutic for glioblastoma multiforme
Cancer Gene Therapy, Published online: 18 July 2019; doi:10.1038/s41417-019-0124-8Viral vector: potential therapeutic for glioblastoma multiforme (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 18, 2019 Category: Cancer & Oncology Authors: Ceera Manikandan Akshita Kaushik Dwaipayan Sen Source Type: research

Notch pathway in ependymoma RELA-fused subgroup: upregulation and association with cancer stem cells markers expression
Cancer Gene Therapy, Published online: 16 July 2019; doi:10.1038/s41417-019-0122-xNotch pathway in ependymoma RELA-fused subgroup: upregulation and association with cancer stem cells markers expression (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 16, 2019 Category: Cancer & Oncology Authors: Taciani de Almeida Magalh ães Gustavo Alencastro Veiga Cruzeiro Graziella Ribeiro de Sousa Keteryne Rodrigues da Silva R égia Caroline Peixoto Lira Carlos Alberto Scrideli Luiz Gonzaga Tone Elvis Terci Valera Kleiton Silva Borges Source Type: research

Discovery and validation of methylated-differentially expressed genes in Helicobacter pylori-induced gastric cancer
Cancer Gene Therapy, Published online: 16 July 2019; doi:10.1038/s41417-019-0125-7Discovery and validation of methylated-differentially expressed genes in Helicobacter pylori-induced gastric cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 16, 2019 Category: Cancer & Oncology Authors: Duanrui Liu Xiaoli Ma Fei Yang Dongjie Xiao Yanfei Jia Yunshan Wang Source Type: research

MicroRNA-4268 inhibits cell proliferation via AKT/JNK signalling pathways by targeting Rab6B in human gastric cancer
Cancer Gene Therapy, Published online: 15 July 2019; doi:10.1038/s41417-019-0118-6MicroRNA-4268 inhibits cell proliferation via AKT/JNK signalling pathways by targeting Rab6B in human gastric cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 15, 2019 Category: Cancer & Oncology Authors: Lingyu Zhao Meng Xue Lu Zhang Bo Guo Yannan Qin Qiuyu Jiang Ruifang Sun Juang Yang Lumin Wang Liying Liu Xiaofei Wang Chen Huang Dongdong Tong Source Type: research

Emerging agents and regimens for treatment of relapsed and refractory acute myeloid leukemia
Cancer Gene Therapy, Published online: 11 July 2019; doi:10.1038/s41417-019-0119-5Emerging agents and regimens for treatment of relapsed and refractory acute myeloid leukemia (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 11, 2019 Category: Cancer & Oncology Authors: Longzhen Cui Yan Liu Yifan Pang Tingting Qian Liang Quan Zhiheng Cheng Yifeng Dai Xu Ye Ying Pang Jinlong Shi Xiaoyan Ke Depei Wu Lin Fu Source Type: research

Recording 25 years of progress in Cancer Gene Therapy
Cancer Gene Therapy, Published online: 09 July 2019; doi:10.1038/s41417-019-0121-yRecording 25 years of progress in Cancer Gene Therapy (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 9, 2019 Category: Cancer & Oncology Authors: Steven K. Libutti Source Type: research

The mutational spectrum of FLT3 gene in acute lymphoblastic leukemia is different from acute myeloid leukemia
Cancer Gene Therapy, Published online: 09 July 2019; doi:10.1038/s41417-019-0120-zThe mutational spectrum of FLT3 gene in acute lymphoblastic leukemia is different from acute myeloid leukemia (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 9, 2019 Category: Cancer & Oncology Authors: Yu Zhang Yang Zhang Fang Wang Mingyu Wang Hong Liu Xue Chen Panxiang Cao Xiaoli Ma Wen Teng Xian Zhang Hongxing Liu Source Type: research

Targeting mTOR suppressed colon cancer growth through 4EBP1/eIF4E/PUMA pathway
Cancer Gene Therapy, Published online: 01 July 2019; doi:10.1038/s41417-019-0117-7Targeting mTOR suppressed colon cancer growth through 4EBP1/eIF4E/PUMA pathway (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 1, 2019 Category: Cancer & Oncology Authors: Huanan Wang Yeying Liu Jie Ding Yuan Huang Jing Liu Nannan Liu Yue Ao Yi Hong Lefeng Wang Lingling Zhang Jiangang Wang Yingjie Zhang Source Type: research

TBL1XR1 is involved in c-Met-mediated tumorigenesis of human nonsmall cell lung cancer
Cancer Gene Therapy, Published online: 27 June 2019; doi:10.1038/s41417-019-0111-0TBL1XR1 is involved in c-Met-mediated tumorigenesis of human nonsmall cell lung cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 27, 2019 Category: Cancer & Oncology Authors: Tiewa Zhang Cheng Liu Yan Yu Jianxiong Geng Qingwei Meng Shanqi Xu Fengrui Zhou Yingying Chen Shi Jin Jing Shen Bo Pan Fanling Meng Fang Liu Source Type: research

Translatable gene therapy for lung cancer using Crispr CAS9—an exploratory review
Cancer Gene Therapy, Published online: 20 June 2019; doi:10.1038/s41417-019-0116-8Translatable gene therapy for lung cancer using Crispr CAS9—an exploratory review (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 20, 2019 Category: Cancer & Oncology Authors: Jishnu Nair Abhishek Nair Soundaram Veerappan Dwaipayan Sen Source Type: research

Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma
Cancer Gene Therapy, Published online: 20 June 2019; doi:10.1038/s41417-019-0112-zPhase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 20, 2019 Category: Cancer & Oncology Authors: Daniella E. Portal Robert E. Weiss Malgorzata Wojtowicz Amal Mansour Claude Monken Janice M. Mehnert Joseph A. Aisner Michael Kane Jennifer Nishioka Seena Aisner Stephen Peters Mark N. Stein Isaac Y. Kim Tina M. Mayer Weichung Shih James Gulley Howard Str Source Type: research

A simplified system for the effective expression and delivery of functional mature microRNAs in mammalian cells
Cancer Gene Therapy, Published online: 20 June 2019; doi:10.1038/s41417-019-0113-yA simplified system for the effective expression and delivery of functional mature microRNAs in mammalian cells (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 20, 2019 Category: Cancer & Oncology Authors: Jiaming Fan Yixiao Feng Ruyi Zhang Wenwen Zhang Yi Shu Zongyue Zeng Shifeng Huang Linghuan Zhang Bo Huang Di Wu Bo Zhang Xi Wang Yan Lei Zhenyu Ye Ling Zhao Daigui Cao Lijuan Yang Xian Chen Bin Liu William Wagstaff Fang He Xiaoxing Wu Jing Zhang Jennifer Source Type: research

A chimeric poxvirus with J2R (thymidine kinase) deletion shows safety and anti-tumor activity in lung cancer models
Cancer Gene Therapy, Published online: 17 June 2019; doi:10.1038/s41417-019-0114-xA chimeric poxvirus with J2R (thymidine kinase) deletion shows safety and anti-tumor activity in lung cancer models (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 17, 2019 Category: Cancer & Oncology Authors: Shyambabu Chaurasiya Nanhai G. Chen Jianming Lu Nikolas Martin Yinan Shen Sang-In Kim Susanne G. Warner Yanghee Woo Yuman Fong Source Type: research

Prognostic value of the FUT family in acute myeloid leukemia
Cancer Gene Therapy, Published online: 17 June 2019; doi:10.1038/s41417-019-0115-9Prognostic value of the FUT family in acute myeloid leukemia (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 17, 2019 Category: Cancer & Oncology Authors: Yifeng Dai Zhiheng Cheng Yifan Pang Yang Jiao Tingting Qian Liang Quan Longzhen Cui Yan Liu Chaozeng Si Jinghong Chen Xu Ye Jingqi Chen Jinlong Shi Depei Wu Xinyou Zhang Lin Fu Source Type: research

Enhanced antitumor efficacy of an oncolytic adenovirus armed with an EGFR-targeted BiTE using menstrual blood-derived mesenchymal stem cells as carriers
Cancer Gene Therapy, Published online: 17 June 2019; doi:10.1038/s41417-019-0110-1Enhanced antitumor efficacy of an oncolytic adenovirus armed with an EGFR-targeted BiTE using menstrual blood-derived mesenchymal stem cells as carriers (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 17, 2019 Category: Cancer & Oncology Authors: Paula Barlab é Jana de Sostoa Carlos Alberto Fajardo Ramon Alemany Rafael Moreno Source Type: research

PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3
Cancer Gene Therapy, Published online: 12 June 2019; doi:10.1038/s41417-019-0094-xPLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3 (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 12, 2019 Category: Cancer & Oncology Authors: Zhipeng Gao Xiaojun Man Zhenhua Li Jianbin Bi Xiankui Liu Zeliang Li Jun Li Zhe Zhang Chuize Kong Source Type: research

Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/GSK-3β/NF-κB signaling pathway
Cancer Gene Therapy, Published online: 11 June 2019; doi:10.1038/s41417-019-0098-6Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/GSK-3β/NF-κB signaling pathway (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 11, 2019 Category: Cancer & Oncology Authors: Shida Yang Xiaobing Zhang Huiling Qu Bo Qu Xiaoxue Yin Hongmei Zhao Source Type: research

PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis
Cancer Gene Therapy, Published online: 05 June 2019; doi:10.1038/s41417-019-0109-7PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 5, 2019 Category: Cancer & Oncology Authors: Subbroto Kumar Saha S. M. Riazul Islam Kyung-Sup Kwak Md. Shahedur Rahman Ssang-Goo Cho Source Type: research

AAV-mediated expression of 3TSR inhibits tumor and metastatic lesion development and extends survival in a murine model of epithelial ovarian carcinoma
Cancer Gene Therapy, Published online: 04 June 2019; doi:10.1038/s41417-019-0108-8AAV-mediated expression of 3TSR inhibits tumor and metastatic lesion development and extends survival in a murine model of epithelial ovarian carcinoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 4, 2019 Category: Cancer & Oncology Authors: Darrick L. Yu Ashley A. Stegelmeier Natalie Chow Amira D. Rghei Kathy Matuszewska Jack Lawler Byram W. Bridle James J. Petrik Sarah K. Wootton Source Type: research

Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma
Cancer Gene Therapy, Published online: 03 June 2019; doi:10.1038/s41417-019-0107-9Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 3, 2019 Category: Cancer & Oncology Authors: Wen Xiao Xuegang Wang Tao Wang Jinchun Xing Source Type: research

HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases
Cancer Gene Therapy, Published online: 03 June 2019; doi:10.1038/s41417-019-0104-zHITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 3, 2019 Category: Cancer & Oncology Authors: Steven C. Katz John Hardaway Ethan Prince Prajna Guha Marissa Cunetta Ashley Moody Li Juan Wang Vincent Armenio N. Joseph Espat Richard P. Junghans Source Type: research

HJURP knockdown disrupts clonogenic capacity and increases radiation-induced cell death of glioblastoma cells
Cancer Gene Therapy, Published online: 29 May 2019; doi:10.1038/s41417-019-0103-0HJURP knockdown disrupts clonogenic capacity and increases radiation-induced cell death of glioblastoma cells (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 29, 2019 Category: Cancer & Oncology Authors: Rodolfo B. Serafim Cibele Cardoso Luis F. M. Di Cristofaro Christiane Pienna Soares Wilson Ara újo Silva Jr Enilza M. Espreafico Maria L. Pa çó-Larson Brendan D. Price Valeria Valente Source Type: research

Identification of leukemia stem cell expression signatures through Monte Carlo feature selection strategy and support vector machine
Cancer Gene Therapy, Published online: 29 May 2019; doi:10.1038/s41417-019-0105-yIdentification of leukemia stem cell expression signatures through Monte Carlo feature selection strategy and support vector machine (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 29, 2019 Category: Cancer & Oncology Authors: JiaRui Li Lin Lu Yu-Hang Zhang YaoChen Xu Min Liu KaiYan Feng Lei Chen XiangYin Kong Tao Huang Yu-Dong Cai Source Type: research

Interleukin-17A polymorphisms predict the response and development of tolerance to FOLFOX chemotherapy in colorectal cancer treatment
Cancer Gene Therapy, Published online: 29 May 2019; doi:10.1038/s41417-019-0102-1Interleukin-17A polymorphisms predict the response and development of tolerance to FOLFOX chemotherapy in colorectal cancer treatment (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 29, 2019 Category: Cancer & Oncology Authors: Sinda Bedoui Meriem Dallel Mouadh Barbirou Mouna Stayoussef Amina Mokrani Amel Mezlini Balkiss Bouhaouala Wassim Y. Almawi Besma Yacoubi-Loueslati Source Type: research

CMV enhancer may not be suitable for tissue-specific enhancement of promoters in cancer gene therapy
Cancer Gene Therapy, Published online: 27 May 2019; doi:10.1038/s41417-019-0106-xCMV enhancer may not be suitable for tissue-specific enhancement of promoters in cancer gene therapy (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 27, 2019 Category: Cancer & Oncology Authors: Zhenyu Jia Jing Jia Shuzhi Zhang Jiang Cao Source Type: research

Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies
Cancer Gene Therapy, Published online: 27 May 2019; doi:10.1038/s41417-019-0101-2Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 27, 2019 Category: Cancer & Oncology Authors: Fernanda I. Staquicini Tracey L. Smith Fenny H. F. Tang Juri G. Gelovani Ricardo J. Giordano Steven K. Libutti Richard L. Sidman Webster K. Cavenee Wadih Arap Renata Pasqualini Source Type: research

CTGF expression is indicative of better survival rates in patients with medulloblastoma
CTGF expression is indicative of better survival rates in patients with medulloblastomaCTGF expression is indicative of better survival rates in patients with medulloblastoma, Published online: 10 May 2019; doi:10.1038/s41417-019-0100-3CTGF expression is indicative of better survival rates in patients with medulloblastoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 10, 2019 Category: Cancer & Oncology Authors: Gustavo Alencastro Veiga Cruzeiro Regia Caroline Peixoto Lira Taciani de Almeida Magalh ães Carlos Alberto Scrideli Elvis Terci Valera Martin Baumgartner Luiz Gonzaga Tone Source Type: research

CTGF expression is indicative of better survival rates in patients with medulloblastoma
CTGF expression is indicative of better survival rates in patients with medulloblastoma, Published online: 10 May 2019; doi:10.1038/s41417-019-0100-3CTGF expression is indicative of better survival rates in patients with medulloblastoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 10, 2019 Category: Cancer & Oncology Authors: Gustavo Alencastro Veiga Cruzeiro Regia Caroline Peixoto Lira Taciani de Almeida Magalh ães Carlos Alberto Scrideli Elvis Terci Valera Martin Baumgartner Luiz Gonzaga Tone Source Type: research

Preferential sensitivity to HDAC inhibitors in tumors with CREBBP mutation
Preferential sensitivity to HDAC inhibitors in tumors with CREBBP mutation, Published online: 09 May 2019; doi:10.1038/s41417-019-0099-5Preferential sensitivity to HDAC inhibitors in tumors with CREBBP mutation (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - May 9, 2019 Category: Cancer & Oncology Authors: Malte Hellwig Daniel J. Merk Beat Lutz Ulrich Sch üller Source Type: research